When Terry Pirovolakis learned his son had an ultra-rare neurodegenerative disease, SPG50, he refused to accept “no options.” What started as a desperate search for hope became Elpida Therapeutics, a nonprofit driving gene therapy innovation for multiple rare diseases. In this episode, Terry shares the remarkable journey from diagnosis to clinical trials, the power of partnerships, and why urgency matters when every day counts.

Show Notes

• From Mystery to Medicine: The Science Behind a Mother’s Search | Podcast
• Taking a Customized and Collaborative Approach to Therapeutic Development | Podcast
• Rare Disease Research for Drug Development | Charles River
• Rare Disease | Charles River
• Discovery | Charles River
• Beyond The Diagnosis